0 Comentários
0 Compartilhamentos
292 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça Login para curtir, compartilhar e comentar!
-
Artificial Intelligence (AI) in Drug Discovery Market: Trends, Forecast, and Competitive Landscape 2025 –2032Executive Summary Artificial Intelligence (AI) in Drug Discovery Market Size and Share Forecast CAGR Value The global artificial intelligence (AI) in drug discovery market was valued at USD 981.64 Million in 2024 and is expected to reach USD 1483.82 Million by 2032 All the data and information involved in this Artificial Intelligence (AI) in Drug Discovery report has been...0 Comentários 0 Compartilhamentos 479 Visualizações 0 Anterior
-
Metastatic Cancer Drug Market Overview: Trends, Challenges, and Forecast 2025 –2032Key Drivers Impacting Executive Summary Metastatic Cancer Drug Market Market Size and Share CAGR Value The global metastatic cancer drug market size was valued at USD 60.68 billion in 2025 and is expected to reach USD 104.25 billion by 2033, at a CAGR of 7.00% during the forecast period A few of the most important objectives of the Metastatic Cancer...0 Comentários 0 Compartilhamentos 157 Visualizações 0 Anterior
-
mRNA Drug Substance and API Market Analysis: Supply Chain, Pricing, and Forecast 2025 –2032Executive Summary mRNA Drug Substance and API Market Research: Share and Size Intelligence CAGR Value The global mRNA drug substance & API market size was valued at USD 940.50 million in 2025 and is expected to reach USD 2,017.60 million by 2033, at a CAGR of 10.00% during the forecast period The credible mRNA Drug Substance and API report has...0 Comentários 0 Compartilhamentos 355 Visualizações 0 Anterior
-
Next-Generation Antibody-Drug Conjugate (ADC) Therapies Market Analysis: Supply Chain, Pricing, and Forecast 2025 –2032Executive Summary Next-Generation Antibody-Drug Conjugate (ADC) Therapies Market Market Size and Share Across Top Segments CAGR Value The global next-generation Antibody-Drug Conjugate (ADC) therapies market size was valued at USD 10.21 billion in 2025 and is expected to reach USD 30.80 billion by 2033, at a CAGR of 14.80% during the forecast period...0 Comentários 0 Compartilhamentos 142 Visualizações 0 Anterior
-
RET Inhibitor Drug Market: Size, Share, and Growth Forecast 2025 –2032Executive Summary RET Inhibitor Drug Market Market Size and Share Forecast CAGR Value The global RET inhibitor drug market size was valued at USD 1.04 billion in 2025 and is expected to reach USD 4.09 billion by 2033, at a CAGR of 18.70% during the forecast period Competitive analysis performed in this RET Inhibitor Drug Market Market report puts forth...0 Comentários 0 Compartilhamentos 155 Visualizações 0 Anterior
-
Drug Device Combination Products Market Market Future Outlook, Trends & Forecast Analysis (2024-2032)Introspective Market Research recently introduced the Drug Device Combination Products Market Market study with 431+ pages of in-depth analysis. The report highlights the Drug Device Combination Products Market industry scope, market outlook, and status (2025–2032). The Drug Device Combination Products Market Market is segmented by key regions,...0 Comentários 0 Compartilhamentos 3K Visualizações 0 Anterior
-
Drug Resistant Virus Treatment Market Growth, Overview and Forecast Analysis By FMINEWARK, DE | The drug resistant virus treatment market stood at USD 12.8 billion in 2026. According to Future Market Insights (FMI), the market is projected to expand to USD 28.6 billion by 2036, reflecting a steady compound annual growth rate (CAGR) of 8.4% over the forecast period. This growth underscores the increasing clinical need for advanced antiviral regimens capable...0 Comentários 0 Compartilhamentos 231 Visualizações 0 Anterior
-
Global ANCA Vasculitis Drug Market Strategic Analysis and Industry ForecastThe Global ANCA Vasculitis Drug Market Size Was Valued at USD 468.89 Million in 2023 and is Projected to Reach USD 765.68 Million by 2032, Growing at a CAGR of 5.6% From 2024-2032. Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis represents a group of rare, severe autoimmune diseases characterized by the inflammation and destruction of small-to-medium blood vessels. The ANCA...0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
-
Global Multiple Drug Resistance Bacterial Infection Treatment Market Share Analysis by Geography – Industry Forecast to 2031The global Multiple Drug Resistance Bacterial Infection Treatment Market is becoming increasingly vital as the incidence of antimicrobial resistance (AMR) escalates across the world. Multidrug‑resistant (MDR) bacterial infections represent a critical public health threat, with resistant pathogens such as Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii reducing the...0 Comentários 0 Compartilhamentos 456 Visualizações 0 Anterior
-
microfluidic organ-on-chip drug testing market Growth, Global Analysis and Forecast Analysis By FMINEWARK, DE | 20 Mar 2026 —The global microfluidic organ-on-chip drug testing market is entering a rapid growth phase as pharmaceutical and biotechnology companies transition from traditional animal and static cell-based assays to dynamic, human-relevant predictive models. Valued at USD 141.5 million in 2025, the market is projected to reach USD 168.0 million in 2026 and surge to USD 932.9...0 Comentários 0 Compartilhamentos 107 Visualizações 0 Anterior
-
Middle East and Africa Artificial Intelligence (AI) in Drug Discovery Market Analysis: Supply Chain, Pricing, and Forecast 2025 –2032Detailed Analysis of Executive Summary Middle East and Africa Artificial Intelligence (AI) in Drug Discovery Market Market Size and Share CAGR Value Data Bridge Market Research analyzes that the Middle East and Africa artificial intelligence (AI) in drug discovery market is expected to reach the value of USD 548.76 million by 2029, at a CAGR of 47.1% during the forecast period. The...0 Comentários 0 Compartilhamentos 134 Visualizações 0 Anterior2
-
“How Industry Leaders Are Winning Big in the $5.76B Microbiome Sequencing Market”Bioinformatics advancements are enhancing the value of microbiome sequencing data interpretation.Sophisticated analytics tools are enabling meaningful insights from complex microbial datasets.Improved data analysis is strengthening confidence in microbiome-based research outcomes. According to analysis by The Insight Partners, the Microbiome Sequencing Services Market size is expected to reach...0 Comentários 0 Compartilhamentos 3K Visualizações 0 Anterior
-
Anti-Radiation Drug Advancements Supporting Global Emergency ResponseThe market is benefiting from rising healthcare infrastructure investments across emerging economies. Improved access to advanced treatments is driving adoption. Growing medical preparedness frameworks support sustained expansion. The Anti-Radiation Drugs Market is expanding steadily as healthcare systems strengthen preparedness for radiation exposure risks across medical, industrial, and...0 Comentários 0 Compartilhamentos 3K Visualizações 0 Anterior
-
Anti-Radiation Drugs Market Size, Share, and Strategic OutlookAdvancements in biotechnology are enabling the development of more targeted radioprotective treatments. These innovations improve cellular protection while minimizing adverse effects. The evolving therapeutic landscape supports sustained market progress. Future OutlookThe Anti-Radiation Drugs Market is expected to register a CAGR of 6.8% from 2025 to 2031, with a market size expanding from US$...0 Comentários 0 Compartilhamentos 2K Visualizações 0 Anterior
-
Competitive Landscape of the Performance Enhancing Drugs MarketGrowing demand for endurance improvement solutions is influencing pharmaceutical development strategies.New drug delivery technologies are enhancing safety and efficacy.Expanding clinical trials are expected to create future growth opportunities. The Performance Enhancing Drugs Market The market is projected to grow at a CAGR of 7.2% from 2025 to 2031, with valuation expected to expand from US$...0 Comentários 0 Compartilhamentos 3K Visualizações 0 Anterior
-
Contract Manufacturing Boom Supporting API CDMO Market ExpansionRegulatory complexity in drug manufacturing is encouraging companies to rely on specialized CDMOs.Expert compliance management reduces operational risks and delays.This support is critical for global market expansion. Active Pharmaceutical Ingredients CDMO market The market is expected to grow steadily at a CAGR of 7.4% from 2025 to 2031, driven by innovation in drug development and the global...0 Comentários 0 Compartilhamentos 3K Visualizações 0 Anterior2
-
Emerging Innovations in the Drugs Infusion System Market LandscapeIncreasing geriatric population levels are boosting the need for continuous drug delivery systems. Long-term therapies require dependable infusion technologies for better care management. This factor is significantly influencing market demand. The Drugs Infusion System Market is expanding steadily as healthcare providers prioritize accurate, automated medication delivery across clinical and...0 Comentários 0 Compartilhamentos 3K Visualizações 0 Anterior
-
Emerging Market Trends Powering the Organoids Services Sector’s 22.3% CAGROrganoid services are research solutions that provide organoid models derived from stem cells. These models replicate the structure and function of organs such as the liver, brain, or intestine. They are valuable for studying complex biological processes. Organoids Services Market Overview The Organoids Services Market is witnessing significant expansion, with its size projected to...0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
-
Geriatric Medicines Market Demand Analysis and Future ProspectsRising healthcare expenditure for elderly care is contributing to consistent market growth. Governments and private institutions are investing in aging population management programs. This financial support enhances the adoption of specialized medicines. The geriatric medicines market is witnessing strong and sustained growth as healthcare systems worldwide adapt to the needs of an aging...0 Comentários 0 Compartilhamentos 3K Visualizações 0 Anterior
-
Global Demand Analysis of the Black Lung Disease MarketTechnological progress in pulmonary diagnostics is accelerating treatment adoption rates.Early intervention models are becoming a key focus in occupational disease management.These advancements are driving sustained demand for therapeutic solutions. The Black Lung Disease Market is progressing steadily as occupational respiratory care gains policy focus and clinical investment. Rising case...0 Comentários 0 Compartilhamentos 2K Visualizações 0 Anterior
-
Global Drug–Device Combination Products Market Is Set for a Rapid Growth and is Expected to Reach USD Billion by 2025-2034The Drug–Device Combination Products market report is intended to function as a supportive means to assess the global Drug–Device Combination Products market along with the complete analysis and clear-cut statistics related to this market. In other words, the report would provide an up-to-date study of the market in terms of its latest trends, present scenario, and the...0 Comentários 0 Compartilhamentos 2K Visualizações 0 Anterior
-
Global Neomycin Market Set to Reach USD 620 Million by 2034 Amid Rising Infection BurdenAccording to a new report from Intel Market Research, the global Neomycin market was valued at USD 420 million in 2025 and is projected to reach USD 620 million by 2034, growing at a steady CAGR of 4.1% during the forecast period (2026–2034). This growth is fueled by rising antibiotic demand in human healthcare and veterinary medicine, coupled with increasing prevalence of bacterial...0 Comentários 0 Compartilhamentos 962 Visualizações 0 Anterior
-
Global Raloxifene Hydrochloride Market Growing at 5.8% CAGR Driven by Dual Benefits in Bone Health & Cancer PreventionAccording to a new report from Intel Market Research, the global Raloxifene Hydrochloride market was valued at USD 1.05 billion in 2025 and is projected to reach USD 1.75 billion by 2034, growing at a steady CAGR of 5.8% during the forecast period (2026-2034). This growth is fueled by increasing osteoporosis prevalence among aging populations, expanding applications in breast cancer prevention,...0 Comentários 0 Compartilhamentos 769 Visualizações 0 Anterior
Páginas Impulsionadas